人生就是博官网

b1banpc.jpg b1banph.jpg

GenSci

Changchun GeneScience Pharmaceutical Co., Ltd (GenSci), is a subsidiary of Changchun High-Tech Industries (Group) Co., Ltd. (CCHT), Stock Code: 000661.SZ

About GenSci

Founded in 1997, GenSci is a pioneer of innovative biopharmaceuticals in China, with nearly three decades of end-to-end experience in R&D, manufacturing, and commercialization.


We made history as the first Chinese biopharma to achieve blockbuster status (>US$1 billion) with an innovative pharmaceutical product — the global first-in-class long-acting rhGH. This milestone defines our DNA of scientific courage.


Today, while our endocrinology heritage remains strong, we are expanding into immunology, respiratory disease, oncology, and beyond. This strategic diversification is already bearing fruit: approximately 70% of our revenue now comes from innovative medicines.


We operate a fully integrated value chain for innovative medicines, adhering to global quality standards, with a footprint spanning the U.S., Europe, Singapore, and Thailand.




324324.jpg
首页-人生就是博(官网)
  • 1997

    Establishment

    首页-人生就是博(官网)
    首页-人生就是博(官网)
  • 8000+

    Employees

    首页-人生就是博(官网)
    首页-人生就是博(官网)
  • 40+

    Serving Countries and Regions

    首页-人生就是博(官网)
    首页-人生就是博(官网)
  • 1,000+

    R&D personnel

    首页-人生就是博(官网)
    首页-人生就是博(官网)
  • 90+

    Patents

    首页-人生就是博(官网)
    首页-人生就是博(官网)
首页-人生就是博(官网)

Our Values

  • 首页-人生就是博(官网) b1img03.jpg
    Integrity

    We are steadfast in our commitment to ethical conduct and regulatory compliance, which forms the bedrock of our enduring legacy. Integrity is more than value; it is the essence of our corporate identity, steering every decision we make.

  • 首页-人生就是博(官网) b1img05.jpg
    Innovation

    Innovation is our driving force. We are tireless in our pursuit of seeking opportunities and embracing differentiation, elevating modest ventures to benchmarks of excellence within our industry.

  • 首页-人生就是博(官网) b1img04.jpg
    Excellence

    With a forward-looking perspective, we shape our present with strategic foresight. We meet every challenge with a pioneering spirit, enhancing our efficiency, and setting unassailable goals that propel us toward excellence.

  • 首页-人生就是博(官网) b1img06.jpg
    Passion

    Central to our ethos is a deep-seated passion for the well-being of our patients and our team. We foster a culture that is rich in compassion and enthusiasm, ensuring that our professional excellence is matched by the genuine care we extend to every individual we engage with.

Milestones

首页-人生就是博(官网) 首页-人生就是博(官网)
首页-人生就是博(官网) 首页-人生就是博(官网)
2026

The First-in-Class in China

Firsekibart Injection(liquid formulation) approved for gouty arthritis treatment

2025

First Out-licensing Deal

GS-098 (TSHR mAb) global ex-China licensing with RTW-backed Yarrow Bioscience focusing on autoimmune thyroid diseases


Partnership with ALK 

Exclusive rights to distribute 3 AIT products  in mainland China


Episil?

Exclusive commercial rights in China


2024

The First-in-Class in China

Jin Beixin?  Firsekibart, breakthrough therapy for acute gouty arthritis(NDA Acceptance)


The First Generics in china Jin Sai Xin* Aqueous SolutionProgesterone Injection()

 

The only drug with a clear oral dosage for cachexia in China

Megaxia? megestrol acetate oral suspension


Jintrolong?PEG-Somatropin

The world's first long-acting growth hormone injection approved for Turner Syndrome





2023

Shanghai Global Innovation Center Inaugurated

To accelerate the R&D process and bring more groundbreaking products and therapies to patients globally


2015

National Science and Technology Progress Second Class Prize

Awarded for excellence in original science and technology


2014

Jintrolong? PEG-rhGH

The world's first long-acting growth hormone injection, taking the lead globally for a decade


2008

Genfulin? Molgramostim Gel

Pioneered as a leading product in wound healing and tissue repair


2005

Jintropin? AQ rhGH Injection

The first liquid recombinant human growth hormone in Asia


1998

Jintropin? rhGH for Injection

The first recombinant human growth hormone produced in China


1997

Establishment of GenSci

Featuring genetic engineering, we began our journey to enhance the health of children with growth deficiencies in China


【网站地图】